CFAR Social and Behavioral Sciences Research Network SBSRN 1st Scientific Meeting Summary Philadelph - PowerPoint PPT Presentation

Title: CFAR Social and Behavioral Sciences Research Network SBSRN 1st Scientific Meeting Summary Philadelph


1
CFAR Social and Behavioral Sciences Research
Network (SBSRN)1st Scientific Meeting
SummaryPhiladelphia, PA October 10 -13, 2006

• SBSRN Executive Committee

2
SBSRN Executive Committee
3
CFAR Representation

• Albert Einstein College of Medicine/Montefiore
  Medical Center
• Baylor College of Medicine/University of Texas
• Brown University/Tufts University/Lifespan
• Case Western Reserve University/University
  Hospitals of Cleveland
• Duke University
• Emory University
• Harvard University Medical School
• John Hopkins University
• New York University College of Medicine

• University of Alabama at Birmingham
• University of California, Los Angeles
• University of California, San Francisco
• University of Colorado
• University of Massachusetts Medical Center
• University of North Carolina, Chapel Hill
• University of Pennsylvania
• University of Washington

4
Other Institutions Represented

• Center for AIDS Intervention Research (CAIR)-
  Medical College of Wisconsin
• Yale University
• Temple University
• Rutgers University
• SUNY- Downstate
• amfAR
• Pangaea

• CDC
• NIAID
• NICHD
• NIMH
• OAR
• NIDA
• HVTN
• Philadelphia Department of Public Health

5
Conference Attendees

• 120 Attendees
• 17 CFARs represented
• 14 other institutions represented
• Characteristics of Attendees
• 65 (54 ) PhD
• 1 (.008) PsyD
• 1 (.008) ScD
• 16 (13) MD
• 12 (10) MPH
• 3 (.02 ) RN/MSN
• 3 (0.2) MSW/LCSW
• 9 (7) Students
• 20 (17) Unknown degree status

6
Mentoring Day Participating CFARs

• University of Pennsylvania
• Harvard University
• Brown University
• Emory University
• University of Alabama at Birmingham

• Montefiore Medical Center
• University of Colorado
• Duke University
• University of Washington
• SUNY Downstate

Not a CFAR
7
Mentoring Day Participants

• 16 Mentees
• 9 CFARs represented
• 1 other institution represented
• Characteristics of Attendees
• 9 (56) PhD
• 4 (25) MD
• 3 (19) MPH
• 1 (.06) DrPH
• 1 (.06) PsyD
• 1 (.06) MS
• 1 (.06) MSN/NP
• 1 (0.6) LCSW

• 5 (31 ) Males
• 11 (69) Females
• 6 (38) Ethnic/Racial minorities

8
Early Career and Transitional Investigators
Mentoring DayOctober 10, 2006

• Mentoring Day Goals
• to provide a team mentoring, supportive and
  collegial atmosphere where early career and
  transitional SBS investigators can meet and
  discuss common challenges they confront in
  establishing interdisciplinary HIV research
  careers
• to assist in addressing this gap by identifying
  promising early career and transitional
  investigators from CFARs around the country,
  providing a daylong orientation and facilitating
  early career and transitional investigator
  linkages with senior CFAR scientists
• to expose early career and transitional
  investigators to a variety of seminars
  specifically tailored to their needs these
  seminars include crafting a successful NIH
  grant mechanisms for support for early career
  and transitional investigators HIV research
  priorities and a brief review of HIV prevention
  research among (a) adolescents, (b) substance
  users, (c) mental health aspects of HIV, (d)
  women, and (e) international HIV prevention
  research
• to provide the opportunity to meet with
  senior-level researchers, and prosper from their
  experiences both successes and failures

9
Early Career and Transitional Investigators
Mentoring DayOctober 10, 2006
10
Early Career and Transitional Investigators
Mentoring DayOctober 10, 2006
11
What Participants Liked Most About Mentoring Day

• The perspective from what really happens at a
  review session and how to write for the reader.
  I have been to many grant writing seminars and
  this was the most helpful for understanding our
  role in writing for the entire process.
• Individualized attention
• Tips on grant writing multiple voices and
  perspectives clarity
• Opportunity to network and connect with other
  early investigators. The video on the grant
  evaluation process was useful

12
Mentoring Day Comments

• I wanted to give you a heart felt thanks for
  organizing and carrying out the mentoring day
  last week.  I got a lot out of it, from the
  presentation on writing NIH grants, to our break
  out discussion, to meeting so many people.  I
  imagine that it took a lot of effort to make the
  day happen, and I wanted to let you know that it
  was a very successful experience for me.  I even
  came up with a new K award idea!
• Again, many thanks, Rae Jean

13
Mentoring Day Comments

• I found the meeting stimulating and was glad to
  have met so many folks with whom I share
  interests/goals. I know that it is extremely
  tough to carve out a 2-day period to accomplish a
  great deal of work, but felt that our working
  group was able to get a good start and make some
  connections with one another. You all did a
  beautiful job of pulling things together.
• Thank you again,
• Cynthia

14
SBSRN Scientific SessionsOctober 11th 12th

• Global Perspective of the HIV Pandemic - Chris
  Beyrer, MD, MPH (Director, Johns Hopkins Fogarty
  AITRP
• Cost Effectiveness Trials in HIV Prevention
  Studies - Stephen Pinkerton, PhD, Center for
  AIDS Intervention Research (CAIR), Medical
  College of Wisconsin)
• Factors Impacting on HIV Prevention and Treatment
  Effectiveness - James Walkup, PhD (Associate
  Professor, Institute for Health, Health Care
  Policy and Aging Research, Rutgers University)
• Examining and Reducing HIV Disparities in Race,
  Class, Gender, and Age - Sevgi Aral, PhD, MSc, MA
  (Associate Director for Science, Division of STD
  Prevention at the Centers for Disease Control
  and Prevention)
• Looking Toward the Future Strategies to
  Identify and Intervene with Persons at Greatest
  Risk of HIV Infections - Thomas Coates, PhD
  (Professor, Division of Infectious Diseases,
  Prevention and Policy Research at the UCLA David
  Geffen School of Medicine Core Scientist,
  CHIPTS)
• Defining, Designing, Implementing and Evaluating
  Effectiveness Trials for
• Vulnerable Populations - Jeffrey Kelly, PhD
  (Director, CAIR, Medical College of Wisconsin)

15
SBSRN Scientific Topics (continued)

• Community Involvement in HIV Research - Steve
  Wakefield (Director, HVTN Legacy Project HIV
  Vaccine Trials Network Hutchinson Cancer
  Research Center)
• Government and Foundations Funding Priorities
  and Strategies for Cross- CFAR Integrated
  Research
• NIH representatives
• Christopher Gordon, PhD (Chief, Secondary HIV
  Prevention Treatment Adherence Div of Mental
  Disorders, Behavioral Research AIDS NIMH)
• David Burns, MD, MPH (DAIDS, Prevention Sciences
  Branch NIAID)
• William Grace, PhD (Behavioral and Social Science
  Research, OAR)
• Susan Newcomer, PhD (Demographic Behavioral
  Science Branch, NICHD)
• Richard Jenkins, PhD (Health Scientist
  Administrator, Prevention Research Branch, NIDA)
• Foundations
• Rowena Johnston, PhD (Acting Director, Public
  Policy AmfAR
• Eric Goosby, MD (Chief Executive Officer Chief
  Medical Officer, Pangaea Global AIDS Foundation)

16
Conference Participants
17
More Conference Participants
18
Scientific Speakers
Jeff Kelly, CAIR
Eric Goosby, Pangaea
Steve Wakefield, HVTN
Thomas Coates, UCLA
19
NIH Representatives
Chris Gordon, NIMH
Susan Newcomer, NICHD
William Grace, OAR
David Burns, NIAID
Richard Jenkins, NIDA
20
Scientific Speaker Evaluations
Did the speakers
A. Deliver the information clearly?
E G 85.8
B. Appear knowledgeable about the information?
E G 95.9
N 120
21
Speaker Evaluations (continued)
Did the speakers
C. Make the information meaningful to your
professional life?
N 119
E G 89.9
D. Provide opportunities for discussion?
E G 94.0
N 117
22
Speaker Evaluations (continued)
Did the speakers
E. Deliver the information in a way for you to
understand?
E G 89.1
N 120
23
Evaluations (continued)
2. What is your overall rating of the Scientific
Session?
E G 90.0
N 118

• How much did the Scientific Session increase your
  interest and
• knowledge regarding HIV/AIDS?

24
Preliminary Outcomes

• Cross-CFAR analysis of mentoring strategies
  James Kahn, UCSF
• Minority investigator recruitment/mentoring
  initiative Michael Marmor, NYU
• Identified 2 sources to develop and host SBSRN
  collaborative website (UAB, UW)
• Identified tentative host sites for annual SBSRN
  conference (UAB 2007, UW 2008, Brown/Harvard
  collaboration 2009)

25
Proposed Action Plan

• JAIDS Journal Supplement (August 2007)
• R13 Conference grant
• SBSRN Listserv
• SBSRN website/web-based directory

26

• Proposed JAIDS Supplement
• Social and Behavioral Sciences Research Network
  Research Lessons Setting the Social and
  Behavioral Sciences Agenda for Future HIV/AIDS
  Research
• Introduction - Metzger, Blank, Wingood,
  DiClemente
• NIH Perspectives on Social Behavioral Science
  Research in the Context of CFAR - Gordon, Young,
  Newcomer, et al.
• Guest Editorial - Hoxie, Curran
• Mentoring the Next Generation of CFAR HIV
  Investigators - Kahn
• Global Perspective of the HIV Pandemic - Beyrer,
  et al.
• Cost Effectiveness Trials in HIV Prevention
  Studies - Pinkerton, et al.
• Factors Impacting on HIV Prevention and Treatment
  Effectiveness
• (Mental Health and Substance Abuse) - Walkup, et
  al.

27

• Examining and Reducing HIV Disparities in Race,
  Class, Gender and Age
• Aral, et al.
• Looking Toward the Future Strategies to
  Identify and Intervene with Persons at Greatest
  Risk of HIV Infections (Prevention with
  Vulnerable Populations)
• Coates, et al.
• Defining, Designing, Implementing, and Evaluating
  Effectiveness Trials for Vulnerable Populations
  (Translational Research and Effectiveness Trials)
• Spielberg, Kelly, et al.
• HIV/AIDS Foundations - Goosby, et al.
• Community Involvement in HIV Research -
  Wakefield, Grundy, et al.
• Recruitment and Training of Minority
  Investigators - Marmor, et al.
• Adapting Evidence-based HIV Prevention Programs
  for Diverse Populations - Wingood, DiClemente
• Conclusions Acknowledgements - DiClemente,
  Wingood, Metzger, Blank

28
What participants liked most about the Scientific
Session

• Cost effectiveness is a new topic for behavioral
  science meeting
• Linking this to the need for research in less
  than ideal conditions
• The development of issues about disparities that
  went beyond blaming the person or the society.
• Stimulated new ways of organizing how to think
  about inputs into disparity excellent,
  stimulating session

29
What Participants Liked Most about the Scientific
Session

• Stimulating thought, discussion, protocol/trial
  development
• Brought out the importance and current lack of
  effectiveness trials
• Attention to structural factors at the same time
  the speaker attended to individual factors. Very
  complex understanding, which is necessary
• Excellent session. Very thoughtful presentation
  implemented by new data linking HIV genetic
  diversity and demographic/ epidemiologic-based
  statistics

30
What Participants Liked Most about the Scientific
Session

• Thoughtful review of the issues and provided some
  new insights on the topic
• Stimulated a lot of thinking
• Clear, up to date, included critical assessments
  of the state of the field
• Forcing me to rethink ideas that I thought I had
  already resolved in my mind.

31
Acknowledgements

• NIH Representatives
• Scientific Speakers
• SBSRN Planning Committee
• All participants